Conflict of interest statement: CONFLICT OF INTEREST: The authors declare thatthey have no competing interests.146. J Breast Cancer. 2018 Jun;21(2):222-226. doi: 10.4048/jbc.2018.21.2.222. Epub2018 Jun 20.Verification of a Western Nomogram for Predicting Oncotype DX™ Recurrence Scores in Korean Patients with Breast Cancer.Kim JM(1), Ryu JM(2), Kim I(2), Choi HJ(2), Nam SJ(2), Kim SW(2), Yu J(2), LeeSK(2), Lee JE(2).Author information: (1)Department of Surgery, Gyeongsang National University Hospital, GyeongsangNational University School of Medicine, Jinju, Korea.(2)Division of Breast and Endocrine Surgery, Department of Surgery, SamsungMedical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.A recent study conducted at the University of Tennessee Medical Center using alarge dataset from the National Cancer Database (NCDB) reported the use ofnomograms for predicting Oncotype DX™ (ODX) scores with clinicopathologic data.We reviewed the data of 218 patients who underwent the ODX test at a singleinstitution in Korea to confirm that nomograms can accurately predict ODX scoregroups using our data, which differ from those of the NCDB in terms of ethnicity.The concordance index (c-index) of nomograms was much lower than that of theUniversity of Tennessee Medical Center for high- and low-risk groups ofcommercial ODX and Trial Assigning Individualized Options for Treatment values.Although the nomogram for predicting ODX scores was based on a large dataset, it could not be generalized to patients in Asia. Further studies using largedatasets of patients from different ethnicities should be performed to develop a nomogram applicable to patients worldwide.DOI: 10.4048/jbc.2018.21.2.222 PMCID: PMC6015974PMID: 29963119 